Lannett Co Inc News Headlines

LCI 
$62.4
*  
2.77
4.25%
Get LCI Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading LCI now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    LCI After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Crush The Market By Completely Ignoring It
2/19/2015 5:00:00 AM - Investopedia


Lannett Has A Bright Future Ahead
2/16/2015 4:31:00 AM - Seeking Alpha


Zacks' Bull Of The Day: Lannett
2/12/2015 6:10:00 AM - Seeking Alpha


Lannett: Strong Execution And Conservative Guidance Leave Room For Upside Surprises
2/11/2015 6:09:00 PM - Seeking Alpha


Update: Shares Of Lannett Only Slightly Higher After Earnings Beat
2/6/2015 3:55:00 AM - Seeking Alpha


Earnings Reported After The Bell Feb. 4
2/5/2015 4:30:00 AM - RTT News


Lannett Company: Pre-Announcement May Suppress Stock's Reaction To Q2 Results
2/2/2015 4:15:00 AM - Seeking Alpha


InsiderInsights.com Daily Round Up 1/29/15: BGG, FPRX, OPK, WIW
1/31/2015 12:09:00 PM - Seeking Alpha


Lannett Sees Q2 Results Above Consensus
1/26/2015 10:51:00 AM - RTT News


UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog
1/19/2015 2:10:00 PM - Investopedia


OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog
1/19/2015 4:10:00 AM - Investopedia


Cempra Reports Positive Results on Antibiotic Solithromycin - Analyst Blog
1/5/2015 5:25:00 AM - Investopedia


NephroGenex Hits 52-Week High on Pyridorin Safety Data - Analyst Blog
1/2/2015 8:40:00 AM - Investopedia


OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog
12/31/2014 2:55:00 PM - Investopedia


2 Generic Drug Makers Worth A Look In 2015
12/31/2014 11:41:00 AM - Seeking Alpha


Cerus Corporation Reports Phase II Red Blood Cells Data - Analyst Blog
12/29/2014 4:00:00 AM - Investopedia


ImmunoGen/Roche's Kadcyla Fails in Study, Shares Plunge - Analyst Blog
12/22/2014 2:44:00 PM - Investopedia


UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
12/18/2014 3:20:00 AM - Investopedia


Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - Analyst Blog
12/17/2014 2:12:00 PM - Investopedia


OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst Blog
12/17/2014 3:10:00 AM - Investopedia


Lannett Co To Present At Oppenheimer Conference; Webcast At 10:55 AM ET
12/10/2014 9:55:00 AM - RTT News


Lannett Appoints Michael Bogda As President - Quick Facts
12/5/2014 8:19:00 AM - RTT News


Update: Lannett Fiscal Q1 2015 Earnings
11/6/2014 2:13:00 AM - Seeking Alpha


A Small-Cap Buy That's Not So Spooky
10/29/2014 2:09:00 PM - Seeking Alpha


Why I'm Not Dumping Small-Caps
10/7/2014 2:48:00 PM - Seeking Alpha